INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $301,000 | -72.1% | 13,040 | -70.1% | 0.00% | -71.4% |
| Q4 2020 | $1,078,000 | -43.1% | 43,626 | -4.6% | 0.01% | -46.2% |
| Q3 2020 | $1,896,000 | +34.0% | 45,726 | +54.9% | 0.01% | +18.2% |
| Q2 2020 | $1,415,000 | +18.1% | 29,526 | +55.2% | 0.01% | 0.0% |
| Q1 2020 | $1,198,000 | -52.7% | 19,026 | -6.9% | 0.01% | -35.3% |
| Q4 2019 | $2,531,000 | +63.5% | 20,426 | -12.4% | 0.02% | +88.9% |
| Q3 2019 | $1,548,000 | -12.0% | 23,326 | +5.4% | 0.01% | -25.0% |
| Q2 2019 | $1,760,000 | +102.8% | 22,126 | +185.1% | 0.01% | +100.0% |
| Q1 2019 | $868,000 | +13.9% | 7,761 | +2.6% | 0.01% | 0.0% |
| Q4 2018 | $762,000 | -22.7% | 7,561 | -3.1% | 0.01% | -25.0% |
| Q3 2018 | $986,000 | – | 7,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |